|
| 37957294 | Achieving net-zero in the dry eye disease care pathway. | Eye (Lond) | 2024 |
| 34102309 | The conjunctival extracellular matrix, related disorders and development of substrates for conjunctival restoration. | Ocul Surf | 2023 |
| 37902271 | How to recognise a Behçet's ulcer from other types of oral ulceration? Defining Behçet's ulceration by an International Delphi Consultation. | Clin Exp Rheumatol | 2023 |
| 37690517 | Conjunctival transcriptomics in ocular mucous membrane pemphigoid. | Ocul Surf | 2023 |
| 37425307 | Severe ocular complications of SJS/TEN and associations among pre-onset, acute, and chronic factors: a report from the international ophthalmology collaborative group. | Front Med (Lausanne) | 2023 |
| 37467894 | Identifying patient-valued outcomes for use in early phase trials of ocular surface disease interventions. | Ocul Surf | 2023 |
| 37201904 | The top 10 research priorities for the treatment of bullous pemphigoid, mucous membrane pemphigoid and pemphigus vulgaris in the UK: results of a James Lind Alliance Priority Setting Partnership. | Br J Dermatol | 2023 |
| 36814255 | Post-acute phase and sequelae management of epidermal necrolysis: an international, multidisciplinary DELPHI-based consensus. | Orphanet J Rare Dis | 2023 |
| 35212705 | History of tonsillectomy is associated with glandular inflammation in Sjögren's disease. | Rheumatology (Oxford) | 2022 |
| 35493740 | Gut Dysbiosis in Ocular Mucous Membrane Pemphigoid. | Front Cell Infect Microbiol | 2022 |
| 35660421 | Deep Metagenomic Sequencing for Endophthalmitis Pathogen Detection Using a Nanopore Platform. | Am J Ophthalmol | 2022 |
| 35361212 | Low density neutrophils are increased in patients with Behçet's disease but do not explain differences in neutrophil function. | J Inflamm (Lond) | 2022 |
| 35589331 | Sjögren's and non-Sjögren's sicca share a similar symptom burden but with a distinct symptom-associated proteomic signature. | RMD Open | 2022 |
| 36460705 | The impact of the first United Kingdom COVID-19 lockdown on environmental air pollution, digital display device use and ocular surface disease symptomatology amongst shielding patients. | Sci Rep | 2022 |
| 36197325 | Clinical Registries in Dry Eye Disease: A Systematic Review. | Cornea | 2022 |
| 31236580 | Disease activity and patient reported outcome measures in Sjögren's - what are the best tools to evaluate? | Rheumatology (Oxford) | 2021 |
| 33628638 | Evaluation of full-length nanopore 16S sequencing for detection of pathogens in microbial keratitis. | PeerJ | 2021 |
| 33536518 | Human leukocyte antigen B*0702 is protective against ocular Stevens-Johnson syndrome/toxic epidermal necrolysis in the UK population. | Sci Rep | 2021 |
| 34407118 | The impact of the COVID-19 pandemic on microbial keratitis presentation patterns. | PLoS One | 2021 |
| 34693022 | Public perceptions of eye symptoms and hospital services during the first UK lockdown of the COVID-19 pandemic: a web survey study. | BMJ Open Ophthalmol | 2021 |
| 34531551 | Patient-reported outcome measures for a large cohort of serum eye drops recipients in the UK. | Eye (Lond) | 2021 |
| 33993465 | British Association of Dermatologists guidelines for the management of people with rosacea 2021. | Br J Dermatol | 2021 |
| 34245180 | European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part I. | J Eur Acad Dermatol Venereol | 2021 |
| 34119712 | Biological tissues and components, and synthetic substrates for conjunctival cell transplantation. | Ocul Surf | 2021 |
| 34370748 | A systematic review assessing the quality of patient reported outcomes measures in dry eye diseases. | PLoS One | 2021 |
| 34309078 | European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part II. | J Eur Acad Dermatol Venereol | 2021 |
| 34307892 | Anxiety and depression in inflammatory eye disease: exploring the potential impact of topical treatment frequency as a putative psychometric item. | BMJ Open Ophthalmol | 2021 |
| 31944132 | Adherence to Topical Medication in Patients with Inflammatory Eye Disease. | Ocul Immunol Inflamm | 2021 |
| 33288899 | Calculating the economic burden of presumed microbial keratitis admissions at a tertiary referral centre in the UK. | Eye (Lond) | 2021 |
| 33369647 | What's new in ocular and oral aspects of Sjögren's syndrome and do new treatments work? | Rheumatology (Oxford) | 2021 |
| 33331922 | The management of Sjögren's syndrome: British Society for Rheumatology guideline scope. | Rheumatology (Oxford) | 2021 |
| 32461564 | Comment on: "Controversies regarding mask usage in ophthalmic units in the United Kingdom during the COVID-19 pandemic". | Eye (Lond) | 2021 |
| 32143010 | Triamcinolone acetonide loaded-cationic nano-lipoidal formulation for uveitis: Evidences of improved biopharmaceutical performance and anti-inflammatory activity. | Colloids Surf B Biointerfaces | 2020 |
| 31693934 | Validation of a clinical assessment tool for cicatrising conjunctivitis. | Ocul Surf | 2020 |
| 33095150 | Mediterranean diet and risk of Sjögren's syndrome. | Clin Exp Rheumatol | 2020 |
| 32678110 | Rapid assessment of ocular drug delivery in a novel ex vivo corneal model. | Sci Rep | 2020 |
| 32366307 | The neuroregenerative effects of topical decorin on the injured mouse cornea. | J Neuroinflammation | 2020 |
| 31055049 | A self-healing hydrogel eye drop for the sustained delivery of decorin to prevent corneal scarring. | Biomaterials | 2019 |
| 29148531 | The Royal College of Ophthalmologists guidelines on serum eye drops for the treatment of severe ocular surface disease: executive summary. | Eye (Lond) | 2018 |
| 30243331 | Dry Eye Disease: Time to Introduce Ocular Surface Stress Tests? | Ophthalmology | 2018 |
| 30588331 | Sustained release of decorin to the surface of the eye enables scarless corneal regeneration. | NPJ Regen Med | 2018 |
| 29698813 | Neurotrophic keratopathy. | Prog Retin Eye Res | 2018 |
| 29442344 | Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjögren's syndrome: examination of data from the UK Primary Sjögren's Syndrome Registry. | Swiss Med Wkly | 2018 |
| 27678525 | Defining Ocular Surface Disease Activity and Damage Indices by an International Delphi Consultation. | Ocul Surf | 2017 |
| 28968900 | Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome Registry. | Rheumatology (Oxford) | 2017 |
| 29148532 | The Royal College of Ophthalmologists guidelines on serum eye drops for the treatment of severe ocular surface disease: full report. | Eye (Lond) | 2017 |
| 28957572 | The British Society for Rheumatology guideline for the management of adults with primary Sjögren's Syndrome. | Rheumatology (Oxford) | 2017 |
| 28957550 | The British Society for Rheumatology guideline for the management of adults with primary Sjögren's Syndrome. | Rheumatology (Oxford) | 2017 |
| 28957549 | The British Society for Rheumatology guideline for the management of adults with primary Sjögren's Syndrome. | Rheumatology (Oxford) | 2017 |
| 29088284 | A qualitative exploration of physical, mental and ocular fatigue in patients with primary Sjögren's Syndrome. | PLoS One | 2017 |